Dissemin is shutting down on January 1st, 2025

Published in

Elsevier, Clinical Lung Cancer, 6(21), p. 498-508.e2, 2020

DOI: 10.1016/j.cllc.2020.06.010

Links

Tools

Export citation

Search in Google Scholar

Immune-related Adverse Events of Pembrolizumab in a Large Real-world Cohort of Patients With NSCLC With a PD-L1 Expression ≥ 50% and Their Relationship With Clinical Outcomes

Journal article published in 2020 by Alessio Cortellini, Alex Friedlaender, Giuseppe L. Banna, Giampiero Porzio, Melissa Bersanelli ORCID, Federico Cappuzzo, Joachim G. J. V. Aerts, Raffaele Giusti, Emilio Bria, Diego Cortinovis, Francesco Grossi, Maria R. Migliorino, Domenico Galetta, Francesco Passiglia, Rossana Berardi and other authors.
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO